91 results match your criteria: "Clemson University School of Health Research[Affiliation]"

The implementation of equine-assisted services (EAS) during treatment for psychological disorders has been frequently documented; however, little is known about the effect of EAS on outcomes for populations with substance use disorder (SUD). The purpose of this scoping review was to synthesize existing literature reporting the effects of EAS when incorporated into SUD treatment. This review followed guidelines in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist for scoping reviews.

View Article and Find Full Text PDF

People who inject drugs (PWID) are a vulnerable population at high risk for acquiring hepatitis C virus (HCV) and frequently suffer from comorbid alcohol use. This study examines the characteristics and correlates of alcohol use among study participants, the association between alcohol consumption and sustained virologic response (SVR) in patients receiving HCV treatment, changes in drinking behaviours during HCV treatment and associations of drinking over time with specific models of HCV treatment. Participants were 150 PWID with HCV who were receiving opioid agonist therapy (OAT) and enrolled in a randomized clinical trial exploring the effectiveness of three models of care for HCV treatment.

View Article and Find Full Text PDF

Don't Take It Lying Down-Vocation as an Antidote to Weltschmerz.

J Grad Med Educ

June 2022

is Program Director, Family Medicine Residency Program, Associate Professor, Prisma Health/University of South Carolina School of Medicine Greenville (Seneca), and Associate Professor, Clemson University School of Health Research.

View Article and Find Full Text PDF

Background: Opioid use disorder (OUD) has led to a staggering death toll in terms of drug-related overdoses. Despite the demonstrated benefits and effectiveness of buprenorphine, retention is suboptimal, and patients typically present with high rates of ongoing polysubstance use during treatment. A pilot trial provided preliminary support for the efficacy of computer-based cognitive-behavioral therapy (CBT4CBT) as an add-on to buprenorphine in reducing substance use.

View Article and Find Full Text PDF

Neglecting physician desires to teach at an academic medical facility: A mixed method investigation of the consequences.

Med Teach

September 2022

Founding Program Director, MAHEC Boone Family Medicine Residency and Clinical Assistant Professor, Department of Family Medicine, University of North Carolina Chapel Hill School of Medicine, Boone, NC, USA.

Purpose: Recent findings have suggested that physicians who spend more time participating in their most meaningful job activities (e.g. teaching) are less likely to experience burnout.

View Article and Find Full Text PDF

Effect of near real-time feedback tool in the electronic medical record on protocol compliance during laparoscopic cholecystectomy: a single-center retrospective analysis.

J Clin Monit Comput

December 2022

Department of Anesthesiology & Perioperative Medicine, Prisma Health - Upstate, 701 Grove Road, Suite 301, 29605, Greenville, SC, United States.

Implementation of evidence-based medicine has proved difficult across medical fields. Leveraging the electronic medical record may improve clinician compliance to published best practices. Our hypothesis was that the use of a near real-time feedback tool would improve compliance to the protocol steps.

View Article and Find Full Text PDF

Purpose: To assess the utility of the radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines (RENAL) nephrometry scoring system at predicting adverse events and outcomes in percutaneous microwave ablation (MWA) of renal tumors.

Materials And Methods: A retrospective review of 116 patients who underwent MWA from 2004 to 2018 at 2 large university hospitals was conducted. Patient demographics and tumor characteristics were collected.

View Article and Find Full Text PDF

Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder.

Drug Alcohol Depend

May 2022

Prisma Health Addiction Research Center, Greenville, SC, USA; Clemson University School of Health Research, Clemson University, Clemson, SC, USA; University of South Carolina School of Medicine, Department of Medicine, Greenville, SC, USA. Electronic address:

Background: Interferon-based regimens exacerbated depressive symptoms, which interfered with treating hepatitis C virus (HCV) among people who inject drugs (PWID). Direct-acting antivirals (DAA) are not associated with worsening depressive symptoms; however, the impact of depressive symptoms on adherence remains little known. We examined the association between depressive symptoms and adherence to DAA among HCV-infected PWID.

View Article and Find Full Text PDF

A Photographic Case of Frostbite Treated with Delayed Hyperbaric Oxygen Therapy.

High Alt Med Biol

June 2022

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of South Carolina School of Medicine, Greenville, South Carolina, USA.

Davis, Ashlee, Brent Sinopoli, Nathaniel Mann, and Antine E. Stenbit. A photographic case of frostbite treated with delayed hyperbaric oxygen therapy.

View Article and Find Full Text PDF

Background: Previous research showed that computerized cognitive behavioral therapy can effectively reduce depressive symptoms. Some mental health apps incorporate gamification into their app design, yet it is unclear whether features differ in their effectiveness to reduce depressive symptoms over and above mental health apps without gamification.

Objective: The aim of this study was to determine whether mental health apps with gamification elements differ in their effectiveness to reduce depressive symptoms when compared to those that lack these elements.

View Article and Find Full Text PDF

Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review.

Drug Alcohol Depend

December 2021

Prisma Health Addiction Research Center, 605 Grove Rd. Suite 205, Greenville, SC, 29605, USA; University of South Carolina School of Medicine Greenville, Department of Medicine, 701 Grove road, Greenville, SC, 29605, USA; Clemson University School of Health Research, 605 Grove Road Suite 301, Clemson, SC, 29605, USA; Prisma Health Department of Internal Medicine, 876 W Faris Rd., Greenville, SC, 29605, USA.

Background: Peer recovery support services (PRSS) have been increasingly incorporated during the recovery process for opioid use disorder (OUD), yet little is known about the effects of PRSS on clinical outcomes of individuals who misuse opioids. This study systematically synthesized existing literature reporting the effectiveness of PRSS interventions on stages of the OUD treatment cascade.

Methods: A search conducted on five databases identified studies from database inception to January 26th 2021 that evaluated the effects of PRSS on PRSS engagement, medication for OUD (MOUD) initiation, MOUD retention, opioid and non-opioid misuse, and remission.

View Article and Find Full Text PDF
Article Synopsis
  • Phelan-McDermid syndrome (PMS) is a rare genetic disorder linked to intellectual disability, autistic traits, speech delays, and seizures, with this study focusing specifically on the prevalence and causes of seizures in affected individuals.
  • In a sample of 57 participants, it was found that 46% experienced seizures, with absence and grand-mal seizures being the most common types, and a strong correlation between seizures and specific genetic mutations, particularly in the SHANK3 gene.
  • The study identified a unique metabolic profile in those with PMS and seizures, indicating disrupted energy utilization, and highlights the importance of these findings for better understanding and managing seizures in patients with PMS.
View Article and Find Full Text PDF

Background: Although efforts to treat hepatitis C virus (HCV) in people who inject drugs (PWID) yield high rates of sustained virologic response (SVR), the relationship between successful HCV treatment and health-related quality of life (HRQOL) among PWID is poorly understood. We examined HRQOL changes throughout HCV treatment and post-treatment for PWID achieving SVR.

Methods: Participants included 141 PWID who achieved SVR following HCV treatment onsite at 3 opioid agonist treatment (OAT) clinics in the Bronx, New York.

View Article and Find Full Text PDF

Objectives: To investigate the race-specific second primary bladder cancer (SPBC) risk following prostatic irradiation.

Methods: Louisiana residents who were diagnosed with localized prostate cancer (PCa) in 1996-2013 and received surgery or radiation were included. Patients were followed until SPBC diagnosis, death, or Dec.

View Article and Find Full Text PDF

People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV). Group treatment is a practical option for addressing barriers to treatment in this population. Prior research on group treatment has resulted in mixed conclusions about its effectiveness in addressing barriers to treatment.

View Article and Find Full Text PDF

Background: Evidence-based practices are shown to improve health outcomes in persons with substance use disorder (SUD), but practice adoption is often limited by stigma. Stigma towards these patients leads to poor communication, missed diagnoses, and treatment avoidance.

Aims: The purpose of this study was to survey a rural community to conceptualize knowledge and attitudes towards SUD and opioid use disorder.

View Article and Find Full Text PDF

Background: Adequate medication adherence is critical for achieving sustained viral response (SVR) of hepatitis C virus (HCV) among people who inject drugs (PWID). However, it is less known which patterns of direct-acting antiviral (DAA) treatment adherence are associated with SVR in this population or what factors are associated with each pattern.

Methods: The randomized 3-arm PREVAIL study used electronic blister packs to obtain daily time frame adherence data in opiate agonist therapy program settings.

View Article and Find Full Text PDF

Background: Beginning in 2019, stepped-wedge designs (SWDs) were being used in the investigation of interventions to reduce opioid-related deaths in communities across the United States. However, these interventions are competing with external factors such as newly initiated public policies limiting opioid prescriptions, media awareness campaigns, and the COVID-19 pandemic. Furthermore, control communities may prematurely adopt components of the intervention as they become available.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the impact of New York State's consent requirement for HIV screening on screening rates, contrasting it with hepatitis C virus (HCV) screening, which does not require consent.
  • - An analysis of 11,938 hospitalized patients in 2015-2016 revealed that 38.5% were screened for HIV compared to 59.1% for HCV, with a significant adjusted risk difference of 22.0% in favor of HCV screening.
  • - The findings indicate that the consent requirement likely hampers routine HIV screening, implying that addressing perceptions and procedural differences between the two screenings is essential for improving public health outcomes related to HIV.
View Article and Find Full Text PDF

High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care.

Int J Drug Policy

July 2021

Department of Medicine, University of South Carolina School of Medicine - Greenville, Greenville, SC, United States; Department of Medicine, Prisma Health-Upstate, Greenville, SC, United States; Clemson University School of Health Research, Clemson, SC, United States.

Background: Though people who inject drugs (PWID) make up the majority of the hepatitis C virus (HCV) epidemic, concerns about adherence often exclude PWID from receiving direct-acting antiviral (DAA) medication. The most effective models of HCV care to promote sustained virologic response (SVR) and high adherence need to be evaluated.

Methods: We conducted a prospective cohort study in three opioid treatment programs (OTPs) in the Bronx, NY.

View Article and Find Full Text PDF

Background: Hepatitis C virus (HCV) frequently co-occurs with symptoms of depression, which are aggravated on interferon-based regimens. However, it is unknown whether HCV treatment with direct-acting antivirals (DAAs) has effects on depressive symptoms among people who inject drugs (PWID). In this study, we examined changes in depressive symptoms during and after HCV treatment among PWID on opioid agonist therapies (OATs).

View Article and Find Full Text PDF

Pediatric High-Grade Gliomas (pHGG) are among the deadliest childhood brain tumors and can be associated with an underlying cancer predisposing syndrome. The thorough understanding of these syndromes can aid the clinician in their prompt recognition, leading to an informed genetic counseling for families and to a wider understanding of a specific genetic landscape of the tumor for target therapies. In this review, we summarize the main pHGG-associated cancer predisposing conditions, providing a guide for suspecting these syndromes and referring for genetic counseling.

View Article and Find Full Text PDF

Introduction: While U.S. jails are critical sites for engagement in HCV care, short lengths-of-stay often do not permit treatment in jail.

View Article and Find Full Text PDF

Adequate adherence to direct-acting antivirals (DAAs) for hepatitis C virus (HCV) is critical to attaining sustained virologic response (SVR). In this PREVAIL study's secondary analyses, we explored the association between self-reported and objective DAAs adherence among a sample of people who inject drugs (PWID) receiving medications for opioid use disorder (MOUD) (N = 147). Self-reported adherence was recoded 3 times during treatment (weeks 4, 8 and 12) using a visual analog scale (VAS), whereas objective adherence was collected continuously during treatment using electronic blister packs.

View Article and Find Full Text PDF